PONZANO, MARTA
 Distribuzione geografica
Continente #
EU - Europa 1.810
Totale 1.810
Nazione #
IT - Italia 1.810
Totale 1.810
Città #
Vado Ligure 632
Genoa 537
Rapallo 373
Genova 246
Bordighera 22
Totale 1.810
Nome #
Impact of tDCS on persistent COVID-19 olfactory dysfunction: a double-blind sham-controlled study 110
The prognostic role of baseline metabolic tumor burden and systemic inflammation biomarkers in metastatic castration-resistant prostate cancer patients treated with Radium-223: A proof of concept study 107
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis 77
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 54
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study) 51
597P Endometrial carcinoma and mismatch repair deficiency: Clinical association and universal screening for Lynch syndrome 50
Cervical musculoskeletal impairments in the 4 phases of the migraine cycle in episodic migraine patients 50
Disability, burden, and symptoms related to sensitization in migraine patients associate with headache frequency 49
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis 49
Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study 47
Dietary antioxidants, non-enzymatic antioxidant capacity and the risk of osteoarthritis in the Swedish National March Cohort 46
Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study 44
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 43
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 42
Quality of life and upper limb disability in Charcot-Marie-Tooth disease: A pilot study 39
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 39
Digital work engagement among Italian neurologists 39
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 39
Coronavirus disease 2019 in Latin American patients with multiple sclerosis 38
Systemic therapy for pre-treated malignant mesothelioma: A systematic review, meta-analysis and network meta-analysis of randomised controlled trials 38
The MuSC-19 study: The Egyptian cohort 35
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination 32
What happens after fingolimod discontinuation? A multicentre real-life experience 32
Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital 31
High-resolution Doppler ultrasound in systemic sclerosis: Analysis of digital arteries and nailfold microvasculature using 18-5 MHz and 33-9 MHz probes 30
Reliability of patient-reported toxicities during adjuvant chemotherapy 30
Patient’s point of view on the use of telemedicine in multiple sclerosis: a web-based survey 30
Aromatase inhibitor-induced bone loss osteosarcopenia in older patients with breast cancer: effects of the RANK/RANKL system’s inhibitor denosumab vs. bisphosphonates 27
Reply to “Cognition and motor phenotypes in ALS: a retrospective study” 25
Increase pain sensitivity during the four phases of the migraine cycle in patients with episodic migraine 24
Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis 24
A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score 23
Urinary phthalate and DINCH metabolite concentrations and gradations of maternal glucose intolerance 23
Development and initial validation of the ONCOREUM score to differentiate childhood cancer with arthropathy from juvenile idiopathic arthritis 23
Assessing the duration of EDSS improvement after a therapy start: A novel approach applied to the long-term extension of the PRISMS study 22
Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry 22
Compressed sensing (CS) MP2RAGE versus standard MPRAGE: A comparison of derived brain volume measurements 22
Blood-brain barrier damage associates with glia-related cytokines in the cerebrospinal fluid of patients with Multiple Sclerosis 22
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 21
Ideal cardiovascular health and risk of death in a large Swedish cohort 21
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis 21
Not all Forms of Muscle Hypertonia Worsen With Fatigue: A Pilot Study in Para Swimmers 21
Profiling migraine patients according to clinical and psychophysical characteristics: clinical validity of distinct migraine clusters 20
Management of the Medico-Legal Dispute of Healthcare-Related SARS-CoV-2 Infections: Evaluation Criteria and Case Study in a Large University Hospital in Northwest Italy from 2020 to 2021 17
Useful outcome measures in INPH patients evaluation 16
Trigeminocervical pain sensitivity during the migraine cycle depends on headache frequency 16
Trigeminal and cervical sensitization during the four phases of the migraine cycle in patients with episodic migraine 16
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease 15
One-year follow-up comparison of two hybrid closed-loop systems in Italian children and adults with type 1 diabetes 15
Profiling migraine patients according to clinical and psychophysical characteristics: a cluster analysis approach 14
Single-Port Cholecystectomy for Cholecystitis Versus Non-Cholecystitis 14
Prevalence of disability improvement in relapsing‐remitting multiple sclerosis patients treated with cladribine tablets 14
Multiple Sclerosis: insights on COVID-19, treatments and inequalities 13
COVID-19 vaccine hesitancy among Italian people with multiple sclerosis 12
Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis 12
High NEDA and No PIRA in Natalizumab-Treated Patients With Pediatric-Onset Multiple Sclerosis 11
Migraine patients with and without neck pain: Differences in clinical characteristics, sensitization, musculoskeletal impairments, and psychological burden 10
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 10
Race and ethnicity in multiple sclerosis phase 3 clinical trials: A systematic review 10
Therapeutic lag: Is treatment effect delayed in progressive MS? 8
Creating an automated tool for a consistent and repeatable evaluation of disability progression in clinical studies for multiple sclerosis 8
Signs and symptoms of Covid-19 in patients with multiple sclerosis 8
Treatment Effect on Brain Atrophy Correlates with Treatment Effect on Cognition in Multiple Sclerosis 8
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge 7
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study 7
Hyper-reflective foci changes in RRMS under natalizumab therapy 5
Mild behavioral impairment as a potential marker of predementia risk states in motor neuron diseases 5
Reinterpreting Clinical Trials in Children With Multiple Sclerosis Using a Bayesian Approach 4
Renal function assessment in older people: comparative analysis of estimation equation with serum creatinine 3
Measuring calf circumference in frail hospitalized older adults and prediction of in-hospital complications and post-discharge mortality 2
Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [18F]PSMA-1007 PET/CT 1
null 1
Totale 1.914
Categoria #
all - tutte 12.784
article - articoli 12.762
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.546


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021110 0 6 25 0 18 38 1 10 4 4 2 2
2021/2022164 1 0 6 7 5 5 5 29 17 23 3 63
2022/2023456 28 29 11 40 77 55 11 42 67 14 67 15
2023/2024454 19 38 4 53 38 90 33 34 16 29 33 67
2024/2025730 83 99 54 122 191 181 0 0 0 0 0 0
Totale 1.914